Climbing Up and Down the AKI Mountain: Navigating Data, Divides, Diagnostics, and Dialysis

Clinical Practice Session

https://www.asn-online.org/education/kidneyweek/2023/program-session-details.aspx?sessId=450308

Session Description

AKI affects approximately 20% of hospitalized patients and is associated with worse long-term outcomes. AKI survivors frequently do not recover to baseline levels of kidney function before discharge, and approximately 10% to 30% will require outpatient dialysis treatments (AKI-D). A variety of diagnostic tools, tests, and tricks are used to prognosticate an AKI survivor’s potential for recovery and, if on dialysis, to promote liberation. This session discusses the evidence for several such assessments and the approach to their application in clinical practice.

ASN thanks the ASN AKINow Recovery/Post-AKI Workgroup and Public Awareness and Education Workgroup for assistance with this session.
Support is provided by an educational grant from 3iveLabs.

Learning Objective(s)

• Articulate key considerations of AKI survivorship from the patient perspective
• Describe the epidemiology of post-AKI outcomes from a patient, provider, and system perspective
• Distinguish CCL14 from other kidney biomarkers in its potential to prognosticate AKI recovery
• Analyze care delivery models used to improve post-AKI outcomes
• Discuss an approach to evaluate patient candidacy for dialysis liberation in AKI-D

Learning Pathway(s)

• AKI and Critical Care
• Dialysis

Moderators

• Anitha Vijayan, MD, FASN
• Ron Wald, MD, MPH

Patient Voice/Commentator

• Marla Levy